Search

Author/Creator Wibbeler, Eva

1. Cerliponase Alfa for the Treatment of Atypical Phenotypes of CLN2 Disease: A Retrospective Case Series. (May 2021)

Authors:
Wibbeler, Eva; Wang, Raymond; Reyes, Emily de los; Specchio, Nicola; Gissen, Paul; Guelbert, Norberto; Nickel, Miriam; Schwering, Christoph; Lehwald, Lenora; Trivisano, Marina; Lee, Laura; Amato, Gianni; Cohen-Pfeffer, Jessica; Shediac, Renée; Leal-Pardinas, Fernanda; Schulz, Angela
Journal:
Journal of child neurology
Issue:
Volume 36:Number 6(2021)
Page Start:
468
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Development of the "Hamburg Best Practice Guidelines for ICV−Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 Patients. (July 2021)

Authors:
Schwering, Christoph; Kammler, Gertrud; Wibbeler, Eva; Christner, Martin; Knobloch, Johannes K.-M.; Nickel, Miriam; Denecke, Jonas; Baehr, Michael; Schulz, Angela
Journal:
Journal of child neurology
Issue:
Volume 36:Number 8(2021)
Page Start:
635
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗